title: REM sleep inhibition by desipramine: evidence for an alpha-1 adrenergic mechanism.
abstract: The acute administration of drugs that block norepinephrine (NE) reuptake suppresses rapid eye movement (REM) sleep in cats and other mammals. The mechanism is presumed to involve NE acting on cells in a pontine REM sleep-generator region. Postsynaptic noradrenergic receptor mechanisms have not been identified. In the present experiments, we tested the ability of the alpha-1 antagonist prazosin and the beta antagonist propranolol to reverse the REM sleep suppression produced by the NE reuptake blocker desipramine (DMI) in the cat. DMI reduced the number of REM sleep episodes, the REM percentage (REM sleep time/total sleep time), and the average REM sleep episode duration. The co-administration of prazosin, but not propranolol, increased the REM percentage and the average REM sleep episode duration toward the placebo level. The co-administration of the peripherally-acting, anti-hypertensive agent hydralazine did not reverse the DMI-induced REM sleep suppression. While the identity of the brain region(s) involved in mediating the alpha-1 noradrenergic suppression of REM sleep by DMI remains unclear, there is reason to consider forebrain structures including the amygdala as well as the pontine areas that generally have been implicated in REM sleep control.
authors.affiliation: Psychiatry Service, Philadelphia Veterans Affairs Medical Center, PA 19104, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Ross
authors.forename: P J
authors.initials: PJ
authors.lastname: Gresch
authors.forename: W A
authors.initials: WA
authors.lastname: Ball
authors.forename: L D
authors.initials: LD
authors.lastname: Sanford
authors.forename: A R
authors.initials: AR
authors.lastname: Morrison
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000494:pharmacology*; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D002415:Cats; D003891:Desipramine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005260:Female; D006830:Hydralazine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012895:Sleep, REM / Q000187:drug effects*
chemical_list: D018759:Adrenergic Uptake Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D006830:Hydralazine; D011433:Propranolol; D003891:Desipramine; D011224:Prazosin